Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaccinex Inc.

0.6995
-0.0305-4.18%
Volume:1.92K
Turnover:1.30K
Market Cap:1.87M
PE:-0.08
High:0.7300
Open:0.7300
Low:0.5800
Close:0.7300
Loading ...
OverviewCompanyNewsFilings

Vaccinex to reports new clinical results on pepinemab at ASCO meeting

TIPRANKS
·
27 May

Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment With Pepinemab to Enhance Immunotherapy in Patients With Head and Neck Cancer at Asco Annual Meeting

THOMSON REUTERS
·
27 May

Top Midday Decliners

MT Newswires Live
·
18 Dec 2024

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

MT Newswires Live
·
18 Dec 2024

Crude Oil Down Over 1%; US Industrial Production Declines In November

Benzinga
·
18 Dec 2024

Vaccinex Shares Tumble 63% On Nasdaq Delisting

Dow Jones
·
18 Dec 2024

Vaccinex Faces Nasdaq Delisting Amid Financial Struggles; Shares Drop 62%

GuruFocus.com
·
18 Dec 2024

Vaccinex Stock to Be Delisted From Nasdaq

MT Newswires Live
·
17 Dec 2024

Vaccinex receives delisting notification from Nasdaq

TIPRANKS
·
17 Dec 2024

Vaccinex Announces Receipt of Delisting Notification From Nasdaq

THOMSON REUTERS
·
17 Dec 2024

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Nov 14, 2024 Post Market
Financial Report Announcement
Aug 14, 2024 Post Market
Financial Report Announcement
May 15, 2024 Post Market
Financial Report Announcement
Apr 02, 2024 Pre-Market
Split&Reverse Split
Feb 20, 2024 14 for 1

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.53
Current
-1.66
Sector Average
82.32%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.53
Maximum
-0.27
+1 STD
-0.73
Minimum
-4.54
-1 STD
-2.59
Average
-1.66

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.